Tuesday, March 28, 2023
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Disclosures for additional planners can be found here.
Assistant Professor
Division of Maternal-Fetal Medicine
Assistant Director of OB Research
Center for Women's Reproductive Health
University of Alabama at Birmingham
Birmingham, Alabama
Associate Professor
Medical Director
Diabetes and Pregnancy Program
Program Director
Maternal-Fetal Medicine Fellowship Program
Division of Maternal-Fetal Medicine
Department of Obstetrics & Gynecology
Oregon Health & Science University
Portland, Oregon
Assistant Professor of Medicine
University of Washington
Diabetes Institute
Seattle, Washington
Professor of Medicine and Obstetrics
Division of Endocrinology, Diabetes, and Metabolism
Director
Mount Sinai Diabetes Center and T1D Clinical Research
Icahn School of Medicine at Mount Sinai
New York, New York
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Physicians - maximum of 0.75 AMA PRA Category 1 Credit(s)™
ABIM Diplomates - maximum of 0.75 ABIM MOC points
Nurses - 0.75 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)
Pharmacists - 0.75 Knowledge-based ACPE (0.075 CEUs)
This activity is intended for obstetricians and gynecologists, nurses, nurse practitioners, pharmacists, and other clinicians managing diabetes in pregnancy.
The goal of this activity is for learners to be better able to use CGM to improve patient outcomes in diabetes and pregnancy.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Disclosures for additional planners can be found here.
Assistant Professor
Division of Maternal-Fetal Medicine
Assistant Director of OB Research
Center for Women's Reproductive Health
University of Alabama at Birmingham
Birmingham, Alabama
Associate Professor
Medical Director
Diabetes and Pregnancy Program
Program Director
Maternal-Fetal Medicine Fellowship Program
Division of Maternal-Fetal Medicine
Department of Obstetrics & Gynecology
Oregon Health & Science University
Portland, Oregon
Assistant Professor of Medicine
University of Washington
Diabetes Institute
Seattle, Washington
Professor of Medicine and Obstetrics
Division of Endocrinology, Diabetes, and Metabolism
Director
Mount Sinai Diabetes Center and T1D Clinical Research
Icahn School of Medicine at Mount Sinai
New York, New York
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Medscape, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.
Awarded 0.75 contact hour(s) of continuing nursing education for RNs and APNs; 0.0 contact hours are in the area of pharmacology.
Medscape, LLC designates this continuing education activity for 0.75 contact hour(s) (0.075 CEUs) (Universal Activity Number JA0007105-0000-23-074-H01-P).
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC / CE Released: 2/24/2023
Valid for credit through: 2/24/2024
processing....
The goal of this activity is for learners to be better able to use continuous glucose monitoring (CGM) to improve patient outcomes in diabetes and pregnancy.
Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.
